Sale!

LDN193189

2 mg

Cat. No.: 36-F52

Original price was: $219.00.Current price is: $119.00.

LDN193189 is a highly potent small molecule BMP inhibitor. It inhibits BMP type I receptors ALK2, ALK3 and ALK6. LDN193189 was derived from structure-activity relationship studies of Dorsomorphin and functions by preventing phosphorylation of Smad1, Smad5 and Smad8. It shows in vivo clinical utility by reducing ectopic ossification in mouse models.

 

Categories: ,

Details

TECHNICAL INFORMATION

Other Names: DM-3189, 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine hydrochloride

Chemical Formula: C₂₅H₂₂N₆ HCl

CAS Number: 1062368-24-4

Molecular Weight: 442.94

Purity:  99% pure

Appearance: Yellow/Orange Powder

Solubility: DMSO and methanol

 

STORAGE AND HANDLING

Storage: Store at 4°C and protected from light. Following reconstitution, store  aliquots at -20°C.

Stability: Stock solutions stable at -20°C for up to 2 years.

Shipping Conditions: Shipped at room temperature.

 

PRODUCT USE

Soluble in DMSO. For a 10mM concentrated stock solution, reconstitute the compound by adding 452 µl of DMSO to the entire contents of the vial. Vortex for 5 minutes.

 

 

References

Yu et al. (2008) BMP type I receptor inhibition reduces heterotopic ossification. Nature Med. 14: 1363-1369.

Cuny et al. (2008) Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. (18)15:4388-92.

Yu et al. (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nature Chem Biol. 4: 33-41.

Tech Docs

Product Specifications

MSDS